NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Contents
- Clinical guidelines update
- 1. Summary section
- 2. Evidence review and recommendations
- 3. References
- 4. Glossary and abbreviations
- Appendices
- Appendix A. Standing Committee members and NICE teams
- Appendix B. Declarations of interest
- Appendix C. Review protocol
- Appendix D. Search strategy
- Appendix E. Review flowchart
- Appendix F. Excluded studies
- Appendix G. Evidence tables
- Appendix H. GRADE profiles
- Appendix I. Economic search strategy
- Appendix J. Economic review flowchart
- Appendix K. Excluded economic studies
Final
Developed by the National Institute for Health and Care Excellence
Disclaimer: Healthcare professionals are expected to take NICE clinical guidelines fully into account when exercising their clinical judgement. However, the guidance does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient and, where appropriate, their guardian or carer.
- NICE Clinical Guideline 155: Psychosis and Schizophrenia in Children and Young People: Recognition and Management
- Psychosis and schizophrenia in children and young people: Evidence Update March 2015: A summary of selected new evidence relevant to NICE clinical guideline 155 'Psychosis and schizophrenia in children and young people: recognition and management' (2013)
- Surveillance report 2016 - Psychosis and schizophrenia in children and young people: recognition and management (2013) NICE guideline CG155
- Addendum to Psychosis and schizophrenia in children and young peopleAddendum to Psychosis and schizophrenia in children and young people
- Microphysogobio elongatus isolate CTOL00424 opsin (RH1) gene, partial cdsMicrophysogobio elongatus isolate CTOL00424 opsin (RH1) gene, partial cdsgi|338808207|gb|JN003299.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...